期刊： DRUG RESISTANCE UPDATES, 2023; 66 ()
Oxaliplatin chemoresistance is a major challenge in the clinical treatment of colorectal cancer (CRC), which is one of the most common malignancies wo......
期刊： DRUG RESISTANCE UPDATES, 2023; 71 ()
The overexpression of the human ATP-binding cassette (ABC) transporters in cancer cells is a common mechanism involved in developing multidrug resista......
期刊： DRUG RESISTANCE UPDATES, 2023; 69 ()
MYC is a proto-oncogene that encodes a powerful regulator of transcription and cellular programs essential for normal development, as well as the grow......
期刊： DRUG RESISTANCE UPDATES, 2023; 68 ()
Bladder cancer is one of the most common malignancies in the world. Cisplatin is one of the most potent and widely used anticancer drugs and has been ......
期刊： DRUG RESISTANCE UPDATES, 2023; 68 ()
Thyroid cancer is the most prevalent endocrine tumor and its incidence is fast-growing worldwide in recent years. Differentiated thyroid cancer (DTC) ......
期刊： DRUG RESISTANCE UPDATES, 2023; 71 ()
Aims: Therapeutic outcome of sorafenib in hepatocellular carcinoma (HCC) is undermined by the development of drug resistance. This study aimed to iden......
期刊： DRUG RESISTANCE UPDATES, 2023; 66 ()
Aims: To investigate the in vivo evolution of the mucoid-phenotype of ST11-KL64 carbapenem-resistant Klebsiella pneumoniae (CRKP) isolated from the sa......
期刊： DRUG RESISTANCE UPDATES, 2023; 70 ()
Purinergic signalling, consisting of extracellular purines and purinergic receptors, modulates cell proliferation, invasion and immunological reaction......
期刊： DRUG RESISTANCE UPDATES, 2023; 67 ()
Aims: To gain insights into the underlying mechanisms of NTP therapy sensitivity and resistance, using the firstever NTP-resistant cell line derived f......
期刊： DRUG RESISTANCE UPDATES, 2023; 67 ()
Corroles provide a remarkable opportunity for the development of cancer theranostic agents among other por-phyrinoids. While most transition metal cor......
期刊： DRUG RESISTANCE UPDATES, 2023; 70 ()
Drug resistance is a major challenge in cancer treatment. The substrates of NAD(P)H:quinone oxidoreductase 1 (NQO1) show a promising anticancer effect......
期刊： DRUG RESISTANCE UPDATES, 2023; 69 ()
Acylphosphatase 1 (ACYP1), a protein located in the mammalian cell cytoplasm, has been shown to be associated with tumor initiation and progression by......
期刊： DRUG RESISTANCE UPDATES, 2023; 70 ()
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for human non-small-cell lung cancer (NSCLC) treatment......
期刊： DRUG RESISTANCE UPDATES, 2023; 68 ()
Aims: To investigate the effect of Klebsiella pneumoniae carbapenemase (KPC)-loaded outer membrane vesicles (OMVs) in protecting Pseudomonas aeruginos......
期刊： DRUG RESISTANCE UPDATES, 2023; 69 ()
Sequence type 235 (ST235) Pseudomonas aeruginosa, harboring so-called international, high-risk, or widespread clones, is associated with relatively hi......
